&#xa0;
defaultWritten evidence submitted by the Department of Health (AMR0043)default&#xa0;defaultIntroduction
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultHow has antimicrobial resistance developed in the past decade? 
default&#xa0;default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultWhat are the gaps in our knowledge about antimicrobial resistance? 
default&#xa0;default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultMulti Drug Resistant BacteriadefaultMetricdefaultKlebsiella - carbapenem
default% non-susceptible to imipenem &amp;/or meropenem
defaultE. coli
default - cephalosporin
default% non-susceptible to cefotaxime &amp;/or
default&#xa0;
defaultceftazidime
defaultE. coli
default - fluoroquinolone
default% non-susceptible to ciprofloxacin
defaultPseudomonas - carbapenem
default% non-susceptible to imipenem &amp;/or meropenem
defaultN. gonorrhoeae
default - ceftriaxone
default% non-susceptible
defaultKlebsiella - cephalosporin
default% non-susceptible to cefotaxime &amp;/or ceftazidime
defaultPseudomonas - cephalosporin
default% non-susceptible to ceftazidime
defaultE. coli
default - gentamicin
default% non-susceptible
defaultS. pneumoniae
default - penicillin
default% non-susceptible
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultIs there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection?  If not, how could this be rectified?
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultWhat measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to control other pathogens? 
default&#xa0;default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultBehaviour change and AMR 
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultWhat global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?
default&#xa0;default&#xa0;
defaultRaising the international profile of AMR
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultThe pipeline of new antibiotics and novel treatments
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultWhat are the strengths and weaknesses of the Government’s 2013-2018 Strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultNovember 2013
default&#xa0;
default&#xa0;
default 
defaulthttp://www.who.int/mediacentre/factsheets/fs194/en/
defaulth
defaultttp://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4078448.pdf
default 
defaulthttp://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf
default 
defaulthttps://www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2
default 
defaultGram-negative bacteria
default are 
defaultbacteria
default that retain 
defaultcrystal violet
default dye in the 
defaultGram staining
default protocol, and are associated with resistance against antibiotics.
default 
defaulthttps://www.gov.uk/government/publications/uk-5-year-antimicrobial-resistance-strategy-2013-to-2018
default 
defaulthttp://www.hpa.org.uk/Publications/InfectiousDiseases/Tuberculosis/1308TBintheUK2013report/
default Gonorrhoea is a sexually acquired infection caused by the bacterium 
defaultNeisseria gonorrhoeae
default.
default 
defaultData drawn from the following sources:
default·
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default Past and current population estimates for England: 
defaulthttp://nww.indicators.ic.nhs.uk/webview/
default; 
default·
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default ONS population projections from HSCIC population statistics database: 
defaulthttps://login.hscic.gov.uk/Login.aspx?version=4&amp;referrer=http%3a%2f%2fmy.hscic.gov.uk%2f&amp;info=http%3a%2f%2fmy.hscic.gov.uk%3a80%2fSignIn.htm
default·
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default PHE Mandatory Surveillance Database of Healthcare Associated Infections.
defaultDH query on the period January 2011 to September 2013.
default&#xa0;
default 
default·
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default Residential Care:
default&#xa0;
default&#xa0;
default&#xa0;
default 
defaulthttp://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/Dilnot_report.pdf
default; 
default&#xa0;
default 
defaulthttp://www.nice.org.uk/media/842/61/HCAIQualityImprovementGuide.pdf
default 
defaulthttp://www.nice.org.uk/nicemedia/live/13683/58591/58591.pdf
default 
defaulthttp://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf
default More information on ESPAUR is available at 
defaulthttp://www.ncbi.nlm.nih.gov/pubmed/24027247
default These were set out at annex C of the UK Five Year Antimicrobial Resistance Strategy (2013).
default 
default2012-2017
default 
defaultThese figures do not include investment in wider underpinning research which is important for increasing knowledge of the basic biology of the organisms or hosts. However the EPSRC data does include investment in developing epidemiological models of infectious diseases, techniques to diagnose and monitor infectious disease and novel antimicrobial therapeutics/agents in response to drug resistance.
default&#xa0;
default See Pharmatimes, September 2013
default UK Five Year Antimicrobial Resistance Strategy; page 16 -20 (2013).
default 
defaulthttp://jac.oxfordjournals.org/content/66/suppl_2/ii41.full
default 
defaulthttps://www.gov.uk/government/publications/the-health-and-social-care-act-2008-code-of-practice-on-the-prevention-and-control-of-infections-and-related-guidance
default.
default 
defaulthttp://www.his.org.uk/files/3813/7088/0820/4_epic2_National_Evidence-Based_Guidelines_for_Preventing_Healthcare-Associated_Infections_in_NHS_Hospitals_in_England_2007.pdf
default&#xa0;
default 
defaulthttps://www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-then-focus
default Prevention and control of infection in care homes - an information resource
defaulthttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/214929/Care-home-resource-18-February-2013.pdf
default&#xa0;
default Antimicrobial prescribing and stewardship competences.
default&#xa0;
default&#xa0;
default Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections and Public Health England.
default&#xa0;
default (September 2013)
defaulthttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/253094/ARHAIprescrcompetencies__2_.pdf
default&#xa0;
default 
defaulthttp://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1294740725984
default.
default 
defaulthttp://www.ncbi.nlm.nih.gov/pubmed/21317398
default 
defaultInterventions to improve antibiotic prescribing practices for hospital inpatients (2013)
defaultPeter Davey, Erwin Brown, Esmita Charani, Lynda Fenelon, Ian M Gould, Alison Holmes, Craig R Ramsay, Philip J Wiffen,
default&#xa0;
default Mark Wilcox.
defaulthttp://www1.imperial.ac.uk/resources/0FFB1648-10D4-4CBD-9472-CA6247A9655D/daveypetalcochranedatabaseofsystematicreviews2013.pdf
default .
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default Ivers N, Jamtvedt G, Flottorp S, Young JM, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012, Issue 6. Art. No.: CD000259. DOI: 10.1002/14651858.CD000259.pub3.
default&#xa0;
default